Nunzia Pharmaceutical Company (NUNZ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 21, 2026
NUNZ Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NUNZ has 434.51 million shares outstanding.
| Current Share Class | 434.51M |
| Shares Outstanding | 434.51M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -52,080.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -270,239.11% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 50,686.94% |
| Weighted Average Cost of Capital (WACC) | -3.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -24.25M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9,900.00% in the last 52 weeks. The beta is -4.54, so NUNZ's price volatility has been lower than the market average.
| Beta (5Y) | -4.54 |
| 52-Week Price Change | +9,900.00% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.95 |
| Relative Strength Index (RSI) | 33.71 |
| Average Volume (20 Days) | 10,798 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -96.97M |
| Pretax Income | -96.99M |
| Net Income | -96.99M |
| EBITDA | n/a |
| EBIT | -96.97M |
| Earnings Per Share (EPS) | -0.23 |
Balance Sheet
The company has 35,373 in cash and 183,345 in debt, with a net cash position of -147,972 or -0.00 per share.
| Cash & Cash Equivalents | 35,373 |
| Total Debt | 183,345 |
| Net Cash | -147,972 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -191,321 |
| Book Value Per Share | -0.00 |
| Working Capital | -191,321 |
Cash Flow
| Operating Cash Flow | -202,004 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NUNZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -42.64% |
| Shareholder Yield | -42.64% |
| Earnings Yield | -223,206.86% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 4, 2019. It was a reverse split with a ratio of 0.0001428.
| Last Split Date | Dec 4, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.0001428 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |